Target intelligence / Profile preview

Colonization factor CS5 (CS5) (CS5)

Target
CS5
Molecular classification
Bacterial adhesin, Fimbrial protein, Surface antigen
01

Overview

Colonization factor CS5 is a major surface-exposed fimbrial protein found on Enterotoxigenic Escherichia coli (ETEC), which is a leading cause of diarrhea in children in developing countries and travelers (Svennerholm et al., 2014). It belongs to the CFA/IV (Colonization Factor Antigen IV) group and is frequently co-expressed with CS6 on the bacterial surface (Wolf, 1997). CS5 facilitates the initial attachment of the bacteria to the human intestinal mucosa, a critical step for subsequent toxin delivery and the development of clinical symptoms (Qadri et al., 2005). The structure of CS5 consists of major and minor subunits that form a pilus structure extending from the bacterial cell wall (Knutton et al., 1989). Because of its essential role in pathogenesis and its high prevalence among clinical ETEC isolates, CS5 is a primary target for the development of oral vaccines, such as ETVAX (Lundgren et al., 2014). These vaccines aim to induce mucosal IgA antibodies that bind to the CS5 fimbriae and sterically hinder the attachment of ETEC to intestinal epithelial cells (Leung et al., 2020). Targeting CS5 provides a strategy to prevent the onset of symptoms by inhibiting colonization rather than treating the infection after it has established. Clinical trials have demonstrated that vaccines targeting CS5 are generally safe and can induce significant immune responses in both adults and children (Qadri et al., 2020).

Other names
CS5 fimbriaeCS5 pilusCFA/IV component CS5Coli surface antigen 5
02

Mechanism of action

Induction of mucosal secretory IgA antibodies that bind to the CS5 fimbriae, thereby sterically hindering the attachment of ETEC to intestinal epithelial cells and preventing colonization.

03

Biological functions

Bacterial adhesionIntestinal colonizationHost-pathogen interaction
04

Disease associations

InfectionTraveler's diarrheaEnterotoxigenic Escherichia coli infection
05

Safety considerations

Antigenic variation among ETEC strainsGastrointestinal side effects associated with oral vaccine administrationPotential for limited cross-protection against non-CS5 expressing strains
06

Interacting drugs

ETVAX

1 more in the full profile.

07

Biomarkers

Anti-CS5 secretory IgA (sIgA) levelsAnti-CS5 serum IgA/IgG titers

Beyond the preview

Go deeper on Colonization factor CS5 (CS5) (CS5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization factor CS5 (CS5) (CS5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call